Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies — Stella

Recruiting

Back to Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina

Key details

Phase

Safety & dosing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

Advanced Research Projects Agency for Health (ARPA-H), Breast Cancer Research Foundation

Enrollment target

~700 participants

Started

February 2026

Primary completion

June 2031

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov